Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec;102(23):9881-9891.
doi: 10.1007/s00253-018-9382-x. Epub 2018 Sep 25.

Biosynthesis of pneumocandin lipopeptides and perspectives for its production and related echinocandins

Yan Li #  1 , Nan Lan #  2 , Lijian Xu  3 , Qun Yue  4
Affiliations
Review

Biosynthesis of pneumocandin lipopeptides and perspectives for its production and related echinocandins

Yan Li et al. Appl Microbiol Biotechnol. 2018 Dec.

Erratum in

Abstract

Fungal diseases are a global public health problem. Invasive fungal infections pose a serious threat to patients with compromised immune systems, such as those undergoing organ or bone marrow transplants, cancer, or HIV/AIDS. Pneumocandins are antifungal lipohexapeptides of the echinocandin family that noncompetitively inhibit of 1,3-β-glucan synthase of fungal cell wall and provide the precursor for the semisynthesis of caspofungin, which is widely used as first-line therapy for invasive fungal infections. Recently, the biosynthetic steps leading to formation of pneumocandin B0 and echinocandin B have been elucidated, and thus, provide a framework and attractive model for further design new antifungal therapeutics around natural variations in echinocandin structural diversities via genetic and chemical tools. In this article, we analyze the biosynthetic pathway of pneumocandins and other echinocandins, provide an update on the array of pneumocandin analogues generated by genetic manipulation, and summarize advances in the enhancement of pneumocandin B0 production by random mutagenesis and fermentation optimization. We also give offer advice on the development of improved pneumocandin drug candidates and more efficient production of pneumocandin B0.

Keywords: Antifungal; Biosynthesis; Echinocandin; Fermentation; Pneumocandin.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adefarati AA, Giacobbe RA, Hensens OD, Tkacz JS (1991) Biosynthesis of L-671,329, an echinocandin-type antibiotic produced by Zalerion arboricola: origins of some of the unusual amino acids and the dimethylmyristic acid side chain. J Am Chem Soc 113(9):3542–3545 - DOI
    1. Adefarati AA, Hensens OD, Jones ETT, Tkacz JS (1992) Pneumocandins from Zalerion arboricola. V. Glutamic acid-derived and leucine-derived amino-acids in pneumocandin A0 (L-671,329) and distinct origins of the substituted proline residues in pneumocandins A0 and B0. J Antibiot 45(12):1953–1957 - DOI
    1. Anonymous (2017) Stop neglecting fungi. Nat Microbiol 2:17120 - DOI
    1. Balkovec JM, Hughes DL, Masurekar PS, Sable CA, Schwartz RE, Singh SB (2014) Discovery and development of first in class antifungal caspofungin (CANCIDAS(R))--a case study. Nat Prod Rep 31(1):15–34 - DOI
    1. Cacho RA, Jiang W, Chooi YH, Walsh CT, Tang Y (2012) Identification and characterization of the echinocandin B biosynthetic gene cluster from Emericella rugulosa NRRL 11440. J Am Chem Soc 134(40):16781–16790 - DOI

LinkOut - more resources